Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Bria

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 25, 2003
Skin testing and hypersensitivity reactions to oxaliplatinC Garufi, A Cristaudo, B Vanni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 13, 2006
Factorial design for randomized clinical trialsE Bria, M Di Maio, C Nisticò, et al.
Cancer Treatment Reviews|September 26, 2021
Efficacy of VEGFR-TKIs plus immune checkpoint inhibitors in metastatic renal cell carcinoma patients with favorable IMDC prognosisC Ciccarese, R Iacovelli, C Porta, et al.
ESMO Open|March 9, 2023
Major adverse cardiac events and cardiovascular toxicity with PARP inhibitors-based therapy for solid tumors: a systematic review and safety meta-analysisA Palazzo, C Ciccarese, R Iacovelli, et al.
Anticancer Research|January 12, 2000
Comparison of CEA, MCA, CA 15-3 and CA 27-29 in follow-up and monitoring therapeutic response in breast cancer patientsS Lauro, L Trasatti, F Bordin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 15, 2005
Chemotherapy-induced amenorrhea in early breast cancerG Ferretti, P Carlini, E Bria, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 28, 2005
Catheter-associated thrombosis: thromboprophylaxis for cancer patients who carry factor V Leiden?G Ferretti, E Bria, A Felici, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 4, 2006
Does low-molecular-weight heparin influence cancer-related mortality?G Ferretti, E Bria, D Giannarelli, et al.
ESMO Open|October 11, 2021
Treating disease progression with osimertinib in EGFR-mutated non-small-cell lung cancer: novel targeted agents and combination strategiesV Di Noia, A D'Aveni, E D'Argento, et al.
Expert Opinion on Pharmacotherapy|February 23, 2016
Tubulin inhibitors in non-small cell lung cancer: looking back and forwardR Ferrara, S Pilotto, U Peretti, et al.
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 25, 2003
Skin testing and hypersensitivity reactions to oxaliplatinC Garufi, A Cristaudo, B Vanni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 13, 2006
Factorial design for randomized clinical trialsE Bria, M Di Maio, C Nisticò, et al.
Cancer Treatment Reviews|September 26, 2021
Efficacy of VEGFR-TKIs plus immune checkpoint inhibitors in metastatic renal cell carcinoma patients with favorable IMDC prognosisC Ciccarese, R Iacovelli, C Porta, et al.
ESMO Open|March 9, 2023
Major adverse cardiac events and cardiovascular toxicity with PARP inhibitors-based therapy for solid tumors: a systematic review and safety meta-analysisA Palazzo, C Ciccarese, R Iacovelli, et al.
Anticancer Research|January 12, 2000
Comparison of CEA, MCA, CA 15-3 and CA 27-29 in follow-up and monitoring therapeutic response in breast cancer patientsS Lauro, L Trasatti, F Bordin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 15, 2005
Chemotherapy-induced amenorrhea in early breast cancerG Ferretti, P Carlini, E Bria, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 28, 2005
Catheter-associated thrombosis: thromboprophylaxis for cancer patients who carry factor V Leiden?G Ferretti, E Bria, A Felici, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 4, 2006
Does low-molecular-weight heparin influence cancer-related mortality?G Ferretti, E Bria, D Giannarelli, et al.
ESMO Open|October 11, 2021
Treating disease progression with osimertinib in EGFR-mutated non-small-cell lung cancer: novel targeted agents and combination strategiesV Di Noia, A D'Aveni, E D'Argento, et al.
Expert Opinion on Pharmacotherapy|February 23, 2016
Tubulin inhibitors in non-small cell lung cancer: looking back and forwardR Ferrara, S Pilotto, U Peretti, et al.
Pageof 6